menu
    • menu

    Company profile for Bluejay Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The mission of Bluejay is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection Develop therapies to cure chronic HBV infection Focus on reduction of HBs antigen (HBsAg) and restoration of adaptive immunity Licensed exclusively global rights to advanced HBV programs Best-in-class anti-HBs-Mab program, fully human IgG1, with clinical candidates identified at pre-GLP to...
    The mission of Bluejay is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection Develop therapies to cure chronic HBV infection Focus on reduction of HBs antigen (HBsAg) and restoration of adaptive immunity Licensed exclusively global rights to advanced HBV programs Best-in-class anti-HBs-Mab program, fully human IgG1, with clinical candidates identified at pre-GLP tox stage and potential to complete Ph1b clinical safety and efficacy studies within 3 years.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bluejay TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Francisco Bay Area California
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://bluejaytx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mirum Pharma Enters into Definitive Agreement to Acquire Bluejay
    Mirum Pharma Enters into Definitive Agreement to Acquire Bluejay

    08 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-08/mirum-pharmaceuticals-enters-into-definitive-agreement-to-acquire-bluejay-therapeutics-expanding-gl

    PHARMIWEB
    08 Dec 2025
    Share Share
    Bluejay's Brelovitug Achieves 100% Virologic Response in Trial
    Bluejay's Brelovitug Achieves 100% Virologic Response in Trial

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184424/0/en/Bluejay-Therapeutics-Brelovitug-BJT-778-Monotherapy-Achieved-100-Virologic-Response-and-up-to-82-Combined-Endpoint-of-Virologic-Response-and-ALT-Normalization-at-Week-48-in-Phase-2.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Bluejay Therapeutic To Present CHD & CHB Data at AASLD Conference
    Bluejay Therapeutic To Present CHD & CHB Data at AASLD Conference

    07 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/07/3162451/0/en/Bluejay-Therapeutics-Announces-Data-Presentations-in-Chronic-Hepatitis-D-CHD-and-Chronic-Hepatitis-B-CHB-at-Upcoming-American-Association-for-the-Study-of-Liver-Diseases-AASLD-The-.html

    GLOBENEWSWIRE
    07 Oct 2025
    Share Share
    Bluejay Begins AZURE-2 Phase 3 Trial for Chronic Hepatitis D
    Bluejay Begins AZURE-2 Phase 3 Trial for Chronic Hepatitis D

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144440/0/en/Bluejay-Therapeutics-Enrolls-First-Patient-in-AZURE-2-Global-Phase-3-Clinical-Trial-Evaluating-Brelovitug-BJT-778-Compared-to-Hepcludex-Bulevirtide-for-Chronic-Hepatitis-D.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    Bluejay Unveils First Preclinical Data for MASH Drug BJT-188
    Bluejay Unveils First Preclinical Data for MASH Drug BJT-188

    07 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/07/3075760/0/en/Bluejay-Therapeutics-Reports-First-Preclinical-Data-for-Liver-Targeted-Fatty-Acid-Synthase-FASN-Inhibitor-BJT-188-Being-Investigated-for-the-Treatment-of-Metabolic-Dysfunction-Asso.html

    GLOBENEWSWIRE
    07 May 2025
    Share Share
    Bluejay Therapeutics to Present Preclinical Data at EASL Congress
    Bluejay Therapeutics to Present Preclinical Data at EASL Congress

    23 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/23/3066398/0/en/Bluejay-Therapeutics-Announces-Upcoming-Presentation-of-Preclinical-Data-in-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH-at-European-Association-for-the-Study-of-the-Liver.html

    GLOBENEWSWIRE
    23 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search